U.S. Markets open in 7 hrs 58 mins

How Is Biogen’s Alzheimers’ Disease Pipeline Positioned in 2019?

Margaret Patrick
How Is Biogen’s Alzheimers’ Disease Pipeline Positioned in 2019?

Gilead Sciences or Biogen: Which Is the Better Biotech Pick?(Continued from Prior Part)Failed programOn March 21, Biogen (BIIB) issued a press release announcing the discontinuation of its Phase 3 trials ENGAGE and EMERGE evaluating its leading